نتائج البحث

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

• Authors : National Cancer Institute (NCI)

• Source: A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic

تفاصيل العنوان

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

• Authors : National Cancer Institute (NCI)

• Source: Phase II Study of Treatment of Acute Promyelocytic Leukemia (APL) With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin (GO)

تفاصيل العنوان

Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer

• Authors : Ruijin Hospital; Yang Li, Professor

• Source: Clinical Research on Efficacy and Safety of Arsenic Trioxide Combined With Chemotherapy in p53-mutated Pediatric Cancer Patients：A

تفاصيل العنوان

Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)

• Authors : Li Junmin, director of the hematology department

• Source: Decitabine and Arsenic Trioxide(ATO) in the Treatment of Myelodysplasic SyndromeChang CK, Zhao YS, Xu F, Guo J, Zhang Z, He Q, Wu D,

تفاصيل العنوان

Frontline Oral Arsenic Trioxide for APL

• Source: Frontline Oral Arsenic Trioxide-based Induction in Newly Diagnosed Acute Promyelocytic LeukaemiaTallman MS, Altman JK. How I treat

تفاصيل العنوان

Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia

• Source: Phase I Trial of Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia

تفاصيل العنوان

Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma

• Authors : Yang Li, Professor

• Source: Clinical Research on Efficacy and Safety of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma：A

تفاصيل العنوان

Oral Arsenic Trioxide for NPM1-mutated AML

• Source: Measurable-residual Disease (MRD) Monitoring of Nucleophosmin 1 (NPM1)-Mutated Acute Myeloid Leukaemia (AML) and Pre-emptive Therapy With Oral Arsenic

تفاصيل العنوان

Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (PANDA-T0)

• Authors : Min Lu, Professor, Ph.D.

• Source: Combination of Decitabine and ATO to Treat AML/MDS Expressing a Classified Type of Mutant p53

تفاصيل العنوان

Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia

• Source: Risk-stratified Frontline Oral Arsenic Trioxide-based Induction in Newly Diagnosed Acute Promyelocytic Leukaemia

تفاصيل العنوان